Sulphasalazine desensitisation in patients with arthritis
Related Experiment Videos
1Department of Rheumatology, Mater Misericordiae Hospital, Dublin.
Irish Journal of Medical Science
|May 1, 1994
Abstract:
Skin rash is a common side effect of sulphasalazine. Desensitisation, with a gradual introduction of the drug, may prevent rash. This study reports a 33% (3/9 patients) success rate of desensitisation in patients with arthritis. Desensitisation should only be attempted if sulphasalazine has been efficacious in treating the joint symptoms.